Experimental therapy of relapsing–remitting multiple sclerosis with copolymer-1

✍ Scribed by Dr Kenneth P. Johnson

• Publisher: John Wiley and Sons
• Year: 1994
• Tongue: English
• Weight: 238 KB
• Volume: 36
• Category: Article
• ISSN: 0364-5134
• DOI: 10.1002/ana.410360727

✦ Synopsis

After steroid therapy was shown to have some effect on multiple sclerosis (MS) in the early 1970s, the next drug that began to excite interest was copolymer-1 (COP-l), a treatment that was shown to inhibit experimental allergic encephalomyelitis (EM) in several mammalian species. We are now coming to a point where we will be able to determine its efficacy, at least in exacerbating-remitting MS. I will briefly describe where the COP-1 program stands at the present time.